Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure
- PMID: 6448866
- PMCID: PMC371540
- DOI: 10.1172/JCI109931
Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure
Abstract
Crosslinked fibrin was digested by plasmin, and three soluble complexes larger than DD/E were purified and characterized. After gel filtration chromatography, the purified complexes were shown to have molecular weights of 465,000, 703,000, and 850,000, as determined by equilibrium sedimentation. Each of the complexes was dissociated into two or more fragments by SDS-polyacrylamide gel electrophoresis. The structure of these subunit fragments was deduced from determinations of their molecular weights and polypeptide chain composition and from known sites of plasmin cleavage of fibrin. Fragments larger than DD have been identified that contain intact gammagamma crosslinks as well as fragments resulting from cleavages at or near this site. The former include DY (mol wt 247,000), YY (mol wt 285,000), DXD (mol wt 461,000), and YXD (mol wt 500,000); and the latter include fragments XD (mol wt 334,000) and XY (mol wt 391,000). A schematic model was developed to explain the structure of the large noncovalently bound complexes based on their molecular weight and observed component fragments. Our scheme supports the two-stranded half-staggered overlap model as the basic unit of fibrin structure, in which each complex consists of fragments from two adjacent complementary antiparallel fibrin strands. The smallest derivative, complex 1, is the DD/E complex; complex 2 contains apposed DY and YD fragments, and complex 3 consists of fragments DXD and YY. Complex 4 is less well-characterized, but its intact structure is projected to consist of YXD and DXY fragments from adjacent fibrin strands. Each complex is heterogeneous in subunit composition, reflecting additional plasmin cleavages within and/or adjacent to its theoretical boundaries. Since most of the protein initially released into solution from degrading fibrin is as complexes larger than DD/E, the derivatives described in this report are likely to be major circulating degradation products of crosslinked fibrin in vivo.
Similar articles
-
A molecular model of plasmic degradation of crosslinked fibrin.Semin Thromb Hemost. 1982 Jan;8(1):25-35. doi: 10.1055/s-2007-1005040. Semin Thromb Hemost. 1982. PMID: 6460319
-
Plasmin degradation of cross-linked fibrin.Ann N Y Acad Sci. 1983 Jun 27;408:397-406. doi: 10.1111/j.1749-6632.1983.tb23260.x. Ann N Y Acad Sci. 1983. PMID: 6223558
-
Plasmic degradation of crosslinked fibrin. I. Structural analysis of the particulate clot and identification of new macromolecular-soluble complexes.Blood. 1980 Sep;56(3):456-64. Blood. 1980. PMID: 6447526
-
Modification of high molecular weight plasmic degradation products of human crosslinked fibrin.Biochim Biophys Acta. 1979 Jan 25;576(1):39-50. doi: 10.1016/0005-2795(79)90482-3. Biochim Biophys Acta. 1979. PMID: 153766
-
Fibrin degradation products. A review of structures found in vitro and in vivo.Ann N Y Acad Sci. 2001;936:594-610. Ann N Y Acad Sci. 2001. PMID: 11460518 Review.
Cited by
-
Relationship between disease severity and D-dimer levels measured with two different methods in pulmonary embolism patients.Multidiscip Respir Med. 2010 Jun 30;5(3):168-72. doi: 10.1186/2049-6958-5-3-168. Multidiscip Respir Med. 2010. PMID: 22958319 Free PMC article.
-
Associations between hemostatic markers and mortality in COVID-19 - Compounding effects of D-dimer, antithrombin and PAP complex.Thromb Res. 2022 May;213:97-104. doi: 10.1016/j.thromres.2022.03.013. Epub 2022 Mar 18. Thromb Res. 2022. PMID: 35316719 Free PMC article.
-
Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation products.Blood Coagul Fibrinolysis. 2016 Jul;27(5):542-50. doi: 10.1097/MBC.0000000000000453. Blood Coagul Fibrinolysis. 2016. PMID: 26656897 Free PMC article.
-
Characterization of the inhibition of fibrin assembly by fibrinogen fragment D.Biochem J. 1981 Sep 1;197(3):661-8. doi: 10.1042/bj1970661. Biochem J. 1981. PMID: 7325975 Free PMC article.
-
Breaking the fibrinolytic speed limit with microwheel co-delivery of tissue plasminogen activator and plasminogen.J Thromb Haemost. 2022 Feb;20(2):486-497. doi: 10.1111/jth.15617. Epub 2021 Dec 19. J Thromb Haemost. 2022. PMID: 34882946 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources